公开(公告)号：US10335534B2

公开(公告)日：2019-07-02

申请号：US15333267

申请日：2016-10-25

Applicant: Medtronic, Inc.

Inventor： Amy Roettger ,  VenKatesh R. Manda ,  John Burnes ,  Rebecca Poindexter ,  Martin T. Gerber

IPC: A61M1/36 ,  G16H50/30 ,  A61M1/34 ,  A61B5/00 ,  A61B5/145 ,  G06F19/00 ,  A61M1/16

Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.